Resources

Read about the latest news and developments at Radient Technologies. To stay up to date on company news, please subscribe to our Mailing List or Contact Us.

News

Radient Announces Q2 2023 Financial Results November 30, 2022
Radient Appoints Interim CEO, Appoints Director, and Announces Financing October 28, 2022
Radient Announces Q1 2023 Financial Results October 21, 2022
Radient Announces FY2022 Financial Results September 30, 2022
RADIENT PROVIDES BI-WEEKLY MCTO STATUS AND OTHER CORPORATE UPDATES September 1, 2022
RADIENT PROVIDES BUSINESS UPDATE AND BI-WEEKLY MCTO STATUS UPDATE August 17, 2022
RADIENT PROVIDES AN UPDATE ON ANNUAL FINANCIAL STATEMENTS FILING August 4, 2022
RADIENT ANNOUNCES POTENTIAL DELAY IN FILING YEAR END FINANCIALS July 26, 2022
Radient Closes First Tranche of Financing July 7, 2022
Radient Announces Hydrocarbon Commercial Production, Pre-Roll Sales Growing Across Canada June 27, 2022
Load More

Financials

2023 Q2 MD&A November 29, 2022
2023 Q2 Financial Statements November 29, 2022
2023 Q1 MD&A June 30, 2022
2023 Q1 Financial Statements June 30, 2022
2022 Year End Financials Statements March 31, 2022
2022 Year End MD&A March 31, 2022
2022 Q3 MD&A February 28, 2022
2022 Q3 Financials Statements February 28, 2022
2022 Q2 MD&A November 29, 2021
2022 Q2 Financials Statements November 29, 2021
Load More

Videos

Video interview with Radient CEO Denis Taschuk | Edmonton Journal March 27, 2019
Interview With Radient CFO Prakash Hariharan | Follow the Money Investor Group March 6, 2019
A Patented Extraction Technology Is On the "MAP" - Radient Technologies April 26, 2018
2018 Venture 50 List - Radient Technologies February 8, 2018
Extraction-tech Developer Radient Looking to Benefit from Cannabis Sector Growth | BNN Bloomberg December 27, 2017

Articles

Talking Extraction: Continuous-Flow Extraction, Quality Control, Challenges, and More February 6, 2020
Radient Technologies: The Science of Medical Cannabis Derivatives | Health Europa December 17, 2019
The CBD Conundrum: Interview with Dave Lafond, Radient's Managing Director of Global Innovation | Cannabis Products Magazine, June 2019 (page 14 - 18) June 17, 2019
Edmonton Cannabis Plant Part of Canadian Push for Global Business: Profile of Radient Technologies | Edmonton Journal March 27, 2019
Liquid Gold: Engineers Strike Oil Making Customized Extracts for Cannabis | Genetic Engineering and Biotechnology News March 14, 2019
Microwave Assisted Cannabis and Hemp Processing: Interview with Radient Founder & CTO Dr. Steven Splinter | CannabisTech March 6, 2019
Exclusive Interview with Aurora Cannabis on International Expansion and their Hemp Portfolio | Equities February 24, 2019
Radient Reduces Nicotine | Tobacco Journal International January 2, 2019
Now You're Cooking! Profile of Radient Technologies | Tobacco Reporter November 22, 2018
Natac Solutions to Usher in a New Wave of Functional Ingredients | Food Navigator USA November 21, 2018
Load More

Whitepapers

All About Cannabidiol (CBD): Information About CBD in Cannabis and Hemp Products Under the New Cannabis Act | Government of Canada March 8, 2019
Radient's Submission to the FDA's Advanced Notice of Proposed Rulemaking for Nicotine Extraction from Tobacco June 11, 2018
World Health Organization's Cannabidiol Pre-Review Report: Expert Committee on Drug Dependence November 6, 2017
Re-Thinking Nicotine and its Effects | Schroeder Institute for Tobacco Research and Policy Studies December 2, 2016
Cannabidiol as a Potential Treatment for Anxiety Disorders | The American Society for Experimental NeuroTherapeutics September 4, 2015
Reducing the Nicotine Content to Make Cigarettes Less Addictive | Tobacco Control April 15, 2013
Canadian Smoking Cessation Clinical Practice Guideline | CAN-ADAPTT/CAMH (© CAN-ADAPTT/CAMH 2012) December 7, 2012
Cannabidiol Enhances Anandamide Signaling and Alleviates Psychotic Symptoms of Schizophrenia | Translational Psychology March 20, 2012
Nicotine Reduction Revisited: Science and Future Directions | Tobacco Control October 19, 2010
Cannabidiol, a Cannabis Sativa Constituent, as an Antipsychotic Drug | Brazilian Journal of Medical and Biological Research December 14, 2005

Corporate Presentation

Corporate Presentation 2021 August 9, 2021

Annual and Special Meeting

Form of Proxy December 29, 2021
Notice and Access December 29, 2021
Financial Statement Request December 29, 2021
Notice and Management Information Circular December 29, 2021

This website contains information about cannabis. Please enter your birthday to confirm that you are of legal age to view our website.

Ce site contient des informations sur le cannabis. Veuillez entrer votre date de naissance pour confirmer que vous avez l'âge légal pour consulter notre site Web.

Submit